HomeCompareBDAFX vs JNJ

BDAFX vs JNJ: Dividend Comparison 2026

BDAFX yields 0.01% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $341.00 in total portfolio value· pulled ahead in Year 7
10 years
BDAFX
BDAFX
● Live price
0.01%
Share price
$28.78
Annual div
$0.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.70
Full BDAFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BDAFX vs JNJ

📍 JNJ pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBDAFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BDAFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BDAFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BDAFX
Annual income on $10K today (after 15% tax)
$0.59/yr
After 10yr DRIP, annual income (after tax)
$0.60/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $703.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BDAFX + JNJ for your $10,000?

BDAFX: 50%JNJ: 50%
100% JNJ50/50100% BDAFX
Portfolio after 10yr
$19.9K
Annual income
$414.24/yr
Blended yield
2.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BDAFX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BDAFX buys
0
JNJ buys
0
No recent congressional trades found for BDAFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBDAFXJNJ
Forward yield0.01%3.36%
Annual dividend / share$0.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$19.7K$20.0K
Annual income after 10y$0.70$827.78
Total dividends collected$7.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BDAFX vs JNJ ($10,000, DRIP)

YearBDAFX PortfolioBDAFX Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,701$0.69$10,676$355.77+$25.00BDAFX
2$11,450$0.69$11,407$389.39+$43.00BDAFX
3$12,253$0.70$12,198$426.53+$55.00BDAFX
4$13,111$0.70$13,056$467.62+$55.00BDAFX
5$14,030$0.70$13,987$513.12+$43.00BDAFX
6$15,012$0.70$14,998$563.56+$14.00BDAFX
7← crossover$16,064$0.70$16,098$619.52$34.00JNJ
8$17,189$0.70$17,295$681.69$106.00JNJ
9$18,393$0.70$18,599$750.82$206.00JNJ
10$19,681$0.70$20,022$827.78$341.00JNJ

BDAFX vs JNJ: Complete Analysis 2026

BDAFXStock

The fund invests primarily in equity securities in the form of common stock of U.S. large-sized companies. The Adviser seeks to invest primarily in what the adviser believes are unique, well-managed, competitively advantaged businesses that generate significant excess free cash flow that is consistently returned to shareholders in the form of stock buybacks and/or dividends.

Full BDAFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BDAFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BDAFX vs SCHDBDAFX vs JEPIBDAFX vs OBDAFX vs KOBDAFX vs MAINBDAFX vs ABBVBDAFX vs MRKBDAFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.